[Possible causes of thrombus-related hazard of a distal splenorenal venous anastomosis].

A distal splenorenal venous anastomosis (DSRVA) is used as a method to decompress the portal system in hypertension and as a method to treat type 1 diabetes mellitus. The essence of the operation consists in establishing an «end-to-side» anastomosis between the distal end of the transected close to the ostium splenic vein with the left renal vein. Possible shortcomings of this operation include but are not limited to high thrombus-related hazard both in case of using it in portal hypertension and in diabetes mellitus.

[Left-side venous anastomosis as a method correcting blood outflow from the kidney].

Case histories and surgical protocols of 50 patients who were treated for chronic hepatitis by creating left-side renoportal venous anastomosis (RPVA) were analysed retrospectively. Early after surgery 75% patients had microhematuria, proteinuria to 0.033-0.

[Anatomic and surgical background for splenorenal venous transposition].

Unilateral portalization of adrenal and renal blood is used in clinical practice for arterial hypertension, chronic hepatitis and type 1 diabetes mellitus management. Left-sided renoportal venous anastomosis (RPVA), spleen vessel ligation and unilateral adrenalectomy (if indicated) are the technical backbone of the intervention. This operation was used for 50 patients with chronic hepatitis.

[New approach to surgical treatment of diabetes mellitus].

Results of palliative operations in three patients with diabetes mellitus were analyzed. Operations were directed to a decrease of activity of counterinsular hormones--glucagon, glucocorticosteroids, catecholamines. In one patient with a coexistent chronic hepatitis a positive effect was obtained after left-side renoportal venous anastomosis with ligation of splenic vessels.